Compare BSX & NEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | NEM |
|---|---|---|
| Founded | 1979 | 1916 |
| Country | United States | United States |
| Employees | N/A | 17500 |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8B | 138.7B |
| IPO Year | 2010 | N/A |
| Metric | BSX | NEM |
|---|---|---|
| Price | $76.53 | $130.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 10 |
| Target Price | ★ $109.15 | $108.90 |
| AVG Volume (30 Days) | ★ 18.5M | 8.3M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | ★ 1.94 | N/A |
| Revenue | ★ $9,076,000,000.00 | N/A |
| Revenue This Year | $12.05 | $13.49 |
| Revenue Next Year | $10.51 | $5.13 |
| P/E Ratio | $39.06 | ★ $19.39 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $72.69 | $41.93 |
| 52 Week High | $109.50 | $134.88 |
| Indicator | BSX | NEM |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 61.94 |
| Support Level | $72.69 | $78.13 |
| Resistance Level | $76.87 | $134.88 |
| Average True Range (ATR) | 1.62 | 4.64 |
| MACD | 0.55 | 0.23 |
| Stochastic Oscillator | 89.47 | 94.39 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 11 mines and interests in two joint ventures in the Americas, Africa, Australia, and Papua New Guinea. The company is expected to sell roughly 5.6 million ounces of gold in 2025 from its core mines after selling six higher-cost, smaller mines following the Newcrest acquisition. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves, along with significant byproduct reserves at the end of December 2024.